Etonogestrel (e.g. Nexplanon®) implant for contraception

Provenance

Written by SPS and the College of Sexual and Reproductive Health (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.

August 2025 – note the Faculty of Sexual and Reproductive Healthcare (FSRH) has now changed its name to the College of Sexual and Reproductive Healthcare (CoSRH). Some web pages and CoSRH documents will continue to display the FSRH name; where you see FSRH, this refers to CoSRH. All weblinks are still active.

Planned Review

Following the December 2025 launch of revised UKMEC guidelines from CoSRH, all reproductive health PGDs are being reviewed to ensure they reflect the updated UKMEC.

Updated versions will be published once approved through the SPS governance process, with an expected publication date of end January 2026.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS Page).

• Etonorgestrel-Implant-National-PGD-template-V2.1-FINAL-Nov 2024Opens in a new window · Word · 70 KB

More reproductive health PGD templates

• Ulipristal acetate 30mg tablets for emergency contraception
• Combined hormonal contraceptive transdermal patch
• Combined hormonal contraceptive vaginal ring
• Medroxyprogesterone acetate (SC-DMPA) injection for contraception
• Lidocaine injection for subdermal etonogestrel in contraception
• Progestogen only pill (POP) for contraception
• Lidocaine plus prilocaine cream for IUD insertion or removal
• Medroxyprogesterone acetate (DMPA) IM injection for contraception
• Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
• Levonorgestrel 1500 microgram tablets for emergency contraception
• Combined oral hormonal contraceptive (COC) in reproductive health
• Lidocaine 10mg/ml spray for IUD insertion or removal
• Copper Intrauterine Device (Cu-IUD)

All PGD templates

Update history